(Q33504052)

27 July 2017

title

Serum transforming growth factor-beta 1 is related to the degree of immunoparesis in patients with multiple myeloma (English)

1 reference

27 July 2017

Kyrtsonis MC

1

1 reference

27 July 2017

Repa C

2

1 reference

27 July 2017

Dedoussis GV

3

1 reference

27 July 2017

Mouzaki A

4

1 reference

27 July 2017

Simeonidis A

5

1 reference

27 July 2017

Stamatelou M

6

1 reference

27 July 2017

Maniatis A

7

1 reference

27 July 2017

publication date

1 July 1998

1 reference

27 July 2017

1 reference

27 July 2017

volume

15

1 reference

27 July 2017

issue

2

1 reference

27 July 2017

page(s)

124-128

1 reference

Transforming growth factor-beta1: differential effects on multiple myeloma versus normal B cells

27 July 2017

cites work

1 reference

12 December 2020

Tumor suppressor activity of the TGF-beta pathway in human cancers

1 reference

12 December 2020

Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome

1 reference

12 December 2020

Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors

1 reference

12 December 2020

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

1 reference

12 December 2020

Heterogenous response of B lymphocytes to transforming growth factor-beta in B-cell chronic lymphocytic leukaemia: correlation with the expression of TGF-beta receptors

1 reference

12 December 2020

Actions and interactions of glucocorticoids and transforming growth factor beta on two related human myeloma cell lines

1 reference

12 December 2020

Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation

1 reference

12 December 2020

Synthesis of transforming growth factor-beta 1 by megakaryocytes and its localization to megakaryocyte and platelet alpha-granules

1 reference

12 December 2020

Deletion of the retinoblastoma gene in multiple myeloma

1 reference

12 December 2020

Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells

1 reference

12 December 2020

Interleukin-6 in human multiple myeloma.

1 reference

12 December 2020

Immunoregulatory mechanisms in multiple myeloma

1 reference

12 December 2020

Increased Intraplatelet and Urinary Transforming Growth Factor-β in Patients with Multiple Myeloma

1 reference

12 December 2020

Prognostic variables and clinical staging in multiple myeloma

1 reference

12 December 2020

Interleukin-4 inhibits growth of multiple myelomas by suppressing interleukin-6 expression

1 reference

12 December 2020

Serum interleukin-6 (IL-6) and interleukin-4 (IL-4) in patients with multiple myeloma (MM)

1 reference

12 December 2020

Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma.

1 reference

12 December 2020

In vivo effects of interleukin-6 on thrombopoiesis in healthy and irradiated primates

1 reference

12 December 2020

Immune dysfunction in mice with plasmacytomas. I. Evidence that transforming growth factor-beta contributes to the altered expression of activation receptors on host B lymphocytes

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02989591

1 reference

Dimensions Publication ID

27 July 2017

1030673231

0 references

1 reference